David Earp is the founder of Circle Pharma. Latest round: Series B. Backed by The Column Group, Nextech Invest, ShangPharma. Based in Oakland, California.
David J. Earp is the President and CEO of Circle Pharma, Inc., a company focused on macrocycle drug discovery and development for intractable cancer targets. Circle Pharma recently raised $45 million in Series B financing led by The Column Group, with participation from Nextech Invest and existing investors ShangPharma, LifeForce Capital, and the Berkeley Catalyst Fund.
Full founder directory · Investor directory · Company funding database · Fundraising library